Inflammatory mechanisms in tendinopathy - towards translation
You might qualify if you meet one of these main criteria: A body mass index (BMI) of 30 kg/m or higher A BMI of 27 kg/m or higher with at least one weight-related health condition Health conditions that support your eligibility include: High blood pressure Type 2 diabetes High cholesterol Heart disease Sleep apnea The FDA expanded semaglutides approval in March 2024
Understanding your genetic profile allows PlexusDx to recommend whether you're a better candidate for gradual tapering, maintenance dosing, or intensive behavioral support after stopping semaglutide
(PubMed) Salih BA, Abasiyanik FM
Cassia M, Alberici F, Gallieni M, Jayne D
Nizari S, Basalay M, Chapman P, Korte N, Korsak A, Christie IN, et al